These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Jaiswal MK Med Res Rev; 2019 Mar; 39(2):733-748. PubMed ID: 30101496 [TBL] [Abstract][Full Text] [Related]
25. [Etiological drug therapy for amyotrophic lateral sclerosis]. Cintas P Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115 [TBL] [Abstract][Full Text] [Related]
28. Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients. Jacob S; Poeggeler B; Weishaupt JH; Sirén AL; Hardeland R; Bähr M; Ehrenreich H J Pineal Res; 2002 Oct; 33(3):186-7. PubMed ID: 12220335 [No Abstract] [Full Text] [Related]
33. Clinical development of levetiracetam for amyotrophic lateral sclerosis. Davies SL; Moral MA Drug News Perspect; 2006 Nov; 19(9):572-3. PubMed ID: 17220961 [TBL] [Abstract][Full Text] [Related]